Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Elisabet de los Pinos — FY2025 total compensation $3,956,167

Elisabet de los Pinos is President, Chief Executive Officer and Director of Aura Biosciences, Inc. (AURA). The company reported total compensation of $3,956,167 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$645,483
Bonus$0
Stock awards$1,492,378
Option awards$1,513,293
Non-equity incentive plan$284,013
Pension and non-qualified deferred compensation$0
All other compensation$21,000
Total$3,956,167

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Aura Biosciences, Inc. filed April 20, 2026, accession 0001193125-26-163933.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President, Chief Executive Officer and Director$645,483$0$1,492,378$1,513,293$284,013$0$21,000$3,956,167
FY2024President, Chief Executive Officer and Director$620,657$0$1,266,005$1,390,125$307,225$0$20,327$3,604,339
FY2023President, Chief Executive Officer and Director$585,525$0$1,240,688$1,400,963$289,835$0$19,800$3,536,811

Totals as disclosed in each year's own compensation disclosure for Aura Biosciences, Inc..

04

The other named executive officers of Aura Biosciences, Inc.

Named executive officerRoleFY2025 total
Elisabet de los Pinos this pagePresident, Chief Executive Officer and Director$3,956,167
Anthony GibneyChief Financial and Business Officer$2,751,226
J. Jill HopkinsChief Medical Officer and President of Research and Development$2,188,965

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Aura Biosciences, Inc. compensation brief.

05

The company page

Elisabet de los Pinos's compensation sits inside Aura Biosciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Aura Biosciences, Inc. (AURA) compensation brief